UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 409

Sortiert nach

The Opioid Epidemic: Crisis and Solutions

Annual review of pharmacology and toxicology, 2018-01, Vol.58, p.143

Skolnick, Phil

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment of overdose in the synthetic opioid era

Pharmacology & therapeutics (Oxford), 2022-05, Vol.233, p.108019-108019, Article 108019

Skolnick, Phil

2022

Link zum Volltext

Verfügbarkeit prüfen

On the front lines of the opioid epidemic: Rescue by naloxone

European journal of pharmacology, 2018-09, Vol.835, p.147-153

Skolnick, Phil

2018

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Discovery, development and implementation of improved options for treating opioid overdose in the synthetic opioid era

Frontiers in psychiatry, 2024-07, Vol.15

2024

Link zum Volltext

Verfügbarkeit prüfen

Comparison of intranasal naloxone and intranasal nalmefene in a translational model assessing the impact of synthetic opioid overdose on respiratory depression and cardiac arrest

Frontiers in psychiatry, 2024-06, Vol.15, p.1399803

2024

Link zum Volltext

Verfügbarkeit prüfen

Triple uptake inhibitors: therapeutic potential in depression and beyond

Expert opinion on investigational drugs, 2007-09, Vol.16 (9), p.1365-1377

2007

Link zum Volltext

Verfügbarkeit prüfen

Anxioselective anxiolytics: on a quest for the Holy Grail

Trends in pharmacological sciences (Regular ed.), 2012-11, Vol.33 (11), p.611-620

Skolnick, Phil

2012

Link zum Volltext

Verfügbarkeit prüfen

Biologic Approaches to Treat Substance-Use Disorders

Trends in pharmacological sciences (Regular ed.), 2015-10, Vol.36 (10), p.628-635

Skolnick, Phil

2015

Link zum Volltext

Verfügbarkeit prüfen

Comment on: Can Intranasal Nalmefene Reduce the Number of Opioid Overdose Deaths?

Clinical pharmacology in drug development, 2024-03, Vol.13 (3), p.317-318

Skolnick, Phil

2024

Link zum Volltext

Verfügbarkeit prüfen

The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf+/− heterozygous null mice

Neuropharmacology, 2012-01, Vol.62 (1), p.391-397

2012

Link zum Volltext

Verfügbarkeit prüfen

Glutamate-based antidepressants: 20 years on

Trends in pharmacological sciences (Regular ed.), 2009-11, Vol.30 (11), p.563-569

2009

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoid1 (CB-1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose

Journal of Neural Transmission, 2020-02, Vol.127 (2), p.279-286

2020

Link zum Volltext

Verfügbarkeit prüfen

Intra- and interstrain differences in models of “behavioral despair”

Pharmacology, biochemistry and behavior, 2001-10, Vol.70 (2), p.187-192

2001

Link zum Volltext

Verfügbarkeit prüfen

Synopsis of Expert Opinions and Conclusions

CNS & neurological disorders drug targets, 2015-01, Vol.14 (6), p.773

2015

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic doses of buspirone block D3 receptors in the living primate brain

The international journal of neuropsychopharmacology, 2014-08, Vol.17 (8), p.1257-1267

2014

Link zum Volltext

Verfügbarkeit prüfen

Harry L June

Neuropsychopharmacology (New York, N.Y.), 2014-12, Vol.39 (13), p.3135-3135

Skolnick, Phil

2014

Link zum Volltext

Verfügbarkeit prüfen

Be positive about negatives–recommendations for the publication of negative (or null) results

European neuropsychopharmacology, 2019-12, Vol.29 (12), p.1312-1320

2019

Link zum Volltext

Verfügbarkeit prüfen

Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose

The Journal of pharmacology and experimental therapeutics, 2019-11, Vol.371 (2), p.409

2019

Link zum Volltext

Verfügbarkeit prüfen

Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatology

Pharmacology, biochemistry and behavior, 2012-11, Vol.103 (1), p.111-118

2012

Link zum Volltext

Verfügbarkeit prüfen

Antidepressants for the new millennium

European Journal of Pharmacology, 1999-06, Vol.375 (1), p.31-40

Skolnick, Phil

1999

Link zum Volltext

Verfügbarkeit prüfen

Response to W. Sieghart

Trends in pharmacological sciences (Regular ed.), 2013-03, Vol.34 (3), p.146-146

Skolnick, Phil

2013

Link zum Volltext

Verfügbarkeit prüfen

Reversal of Opioid‐Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone

Journal of clinical pharmacology, 2024-07, Vol.64 (7), p.828-839

2024

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain

The Journal of pharmacology and experimental therapeutics, 2007-06, Vol.321 (3), p.1208

2007

Link zum Volltext

Verfügbarkeit prüfen

Triple reuptake inhibitors ("broad spectrum" antidepressants)

CNS & neurological disorders drug targets, 2007-04, Vol.6 (2), p.141

2007

Link zum Volltext

Verfügbarkeit prüfen

Current perspectives on the development of non-biogenic amine-based antidepressants

Pharmacological research, 2001-05, Vol.43 (5), p.411-422

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 409

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(392)
Mit Volltextzugriff
(365)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Opioid Epidemic: Crisis and Solutions

Treatment of overdose in the synthetic opioid era

On the front lines of the opioid epidemic: Rescue by naloxone

Editorial: Discovery, development and implementation of improved options for treating opioid overdose in the synthetic opioid era

Comparison of intranasal naloxone and intranasal nalmefene in a translational model assessing the impact of synthetic opioid overdose on respiratory depression and cardiac arrest

Triple uptake inhibitors: therapeutic potential in depression and beyond

Anxioselective anxiolytics: on a quest for the Holy Grail

Biologic Approaches to Treat Substance-Use Disorders

Comment on: Can Intranasal Nalmefene Reduce the Number of Opioid Overdose Deaths?

The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf+/− heterozygous null mice

Glutamate-based antidepressants: 20 years on

Cannabinoid1 (CB-1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose

Intra- and interstrain differences in models of “behavioral despair”

Synopsis of Expert Opinions and Conclusions

Therapeutic doses of buspirone block D3 receptors in the living primate brain

Harry L June

Be positive about negatives–recommendations for the publication of negative (or null) results

Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose

Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatology

Antidepressants for the new millennium

Response to W. Sieghart

Reversal of Opioid‐Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone

Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain

Triple reuptake inhibitors ("broad spectrum" antidepressants)

Current perspectives on the development of non-biogenic amine-based antidepressants

Suchergebnisse filtern